Skip to main content
European Commission logo
Enterprise Europe Network

Polish producer of medicinal products seeks distributors and financial or strategic investors

Summary

Profile Type
  • Business Offer
POD Reference
BOPL20240208006
Term of Validity
8 February 2024 - 7 February 2026
Company's Country
  • Poland
Type of partnership
  • Commercial agreement
Targeted Countries
  • Germany
  • North Macedonia
  • Denmark
  • United Arab Emirates
  • Czechia
  • Croatia
  • Ukraine
  • Egypt
  • Sweden
  • Finland
  • Bosnia and Herzegovina
  • Slovenia
  • Portugal
  • Spain
  • Italy
  • Slovakia
  • Luxembourg
  • Estonia
  • France
  • Romania
  • Latvia
  • Bulgaria
  • Belgium
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
The Polish company established in 1996 runs the production of medical products, offering 52 registers for medicinal products for various purposes and pharmaceutical forms, as well as cosmetic products and dietary supplements. It sells its products in Poland and also exports to Georgia, Armenia, Azerbaijan, Lithuania, Ukraine. The company is looking for distributors and investors (strategic or financial).
Full Description
The offer includes ready-made forms: syrups, ointments, gels, creams, drops, suspensions, tablets. These include preparations based on plant products (dry aqueous and water ethanol extracts), defined by the DER index, in accordance with EMA requirements,
with a well established position in traditional medicine, documented and acceptable safety and effectiveness profile, e g syrups (original method for testing the stability of mucus using the polysaccharide method).

Production activities are carried out in the production of non-sterile medicinal products for humans (main profile - 52 registers) and dietary supplements, cosmetics and medical devices. The company also develops contract production.

Manufacturing processes concern the following activities: purchasing materials (initial and packaging), production, control activities related to the supervision of individual manufacturing operations, releasing medicinal products for circulation, storage and distribution.
Advantages and Innovations
- basic profile – production and import of non - sterile medicines for human use, license granted by Main Pharmaceutical Inspectorate,
- own Microbiological Laboratory and Chemical Laboratory with a total area of approx. 280 m2,
- Active API distributor registry certificate,
- Ephedrine processing certificate,
- NATO code of trusted company - possibility to deliver the goods to all NATO bases all over the world,
- Experienced and educated core team of specialists, possibility to increase the production staff according to the needs, historically max. over 100 staff members.
Stage of Development
  • Already on the market
Sustainable Development Goals
  • Not relevant
IPR status
  • Secret know-how

Partner Sought

Expected Role of a Partner
The company is open for discussion in the selected areas and it's looking for:
• Contract clients (the company can offer medicines, dietary supplements, OTC products)
• Distributors,
• Financial or strategic investors.
Type and Size of Partner
  • SME 11-49
  • SME 50 - 249
  • Big company
Type of partnership
  • Commercial agreement

Dissemination

Market keywords
  • 05007002 - Pharmaceuticals/fine chemicals
Targeted countries
  • Germany
  • North Macedonia
  • Denmark
  • United Arab Emirates
  • Czechia
  • Croatia
  • Ukraine
  • Egypt
  • Sweden
  • Finland
  • Bosnia and Herzegovina
  • Slovenia
  • Portugal
  • Spain
  • Italy
  • Slovakia
  • Luxembourg
  • Estonia
  • France
  • Romania
  • Latvia
  • Bulgaria
  • Belgium